Abstract:Background: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor with a wide range of biological behaviors, and activating mutations of KIT are particularly crucial to its development. Long non-coding RNAs (lncRNAs) have been identified as an oncogene in multiple cancer types, but data in GIST are missing. The aim of the study was to evaluate the contribution of lncRNA H19 to the malignant course of GISTs.Materials and Methods: RNA-seq analysis of lncRNA expression in five paired GIST and ANTs were analyzed to screen for differentially expressed lncRNAs. 274 human lncRNAs analyzed, exhibited significantly differential expressions with 186 genes being up-regulated and 88 genes being down-regulated compared to ANT (fold change>5, p<0.05). Unsupervised hierarchical clustering identified 48 lncRNAs and lncRNA H19 was the most overexpressed novel one. To assess the clinical importance of lncRNA H19 upregulation in GISTs, based on the expression levels 92 GIST patients were categorized into two groups: high (n=46) and low (n=46) lncRNA H19 expression.Results: After identifying lncRNA H19 as the most important one, validation in the expanded cohort confirmed the frequent upregulation of lncRNA H19 in GIST. Functional assays revealed that lncRNA H19 promotes GIST cell proliferation and metastasis. We could demonstrate that lncRNA H19 was predicted to sponge 19 miRNAs with six potential binding sites shared with KIT 3’-UTR using bio-informative database analysis. It was confirmed that lncRNA H19 was positively correlated with the expression of KIT, and the knockdown of lncRNA H19 led to the depression of KIT and its downstream pathway. Using luciferase reporter assays, lncRNA H19 was observed to sponge several miRNAs including miR-18a/b-5p, miR-19a/b-3p, miR-193a/b-3p, miR-216b-5p and mIR-3666. The combination of lncRNA H19 and KIT inhibition showed increased growth inhibition in GIST cell lines. Taken together, the data indicate that lncRNA H19 functions as a competing endogenous RNA (ceRNA) of KIT and promotes GIST progression. It could be shown that the expression levels of lncRNA H19 were significantly correlated with the progression markers of GIST, tumor size (P<0.001), mitosis count (P<0.001), and the modified NIH risk criteria (P<0.001)Conclusion: Our results indicate that lncRNA H19 can affect imatinib-induced apoptotic cell death and play a role in facilitating GIST progression by modulating the expression of KIT through the ceRNA network. High lncRNA H19 expression is associated with worse prognosis in patients with GIST and lncRNA H19 may serve as a new predictor of prognosis. Furthermore, targeting lncRNA H19/KIT ceRNA network appears to be a promising treatment for GIST.Citation Format: Peter Hohenberger, Lin Tu, Wenyi Zhao, Ming Wang Wang, Zizheng Zhang, Heike Allgayer, Hui Cao. Long non-coding RNAH19 as a competing endogenous RNA of KIT in the progression of GIST [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 758.

CeRNA Expression Profiling Identifies KIT-Related Circrna-Mirna-mrna Networks in Gastrointestinal Stromal Tumour.

Identification of CircRNA–miRNA–mRNA Regulatory Network in Gastrointestinal Stromal Tumor

Crosstalk Between Circrnas and the PI3K/AKT And/or MEK/ERK Signaling Pathways in Digestive Tract Malignancy Progression.

Potential Value of Circular RNA circTBC1D4 in Gastrointestinal Stromal Tumors

Analysis of Potential Circular RNAs in Regulating Imatinib Resistance of Gastrointestinal Stromal Tumor

The Potential circRNAs in Imatinib Resistance of GIST

circ_SMA4 promotes gastrointestinal stromal tumors malignant progression by sponging miR-494-3p/KIT axis and activating JAK/STAT pathway

Mir-148B-3p Functions As a Tumor Suppressor in GISTs by Directly Targeting KIT

Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer

Extensive Profiling of Circular RNAs and the Potential Regulatory Role of Circrna-000284 in Cell Proliferation and Invasion of Cervical Cancer Via Sponging Mir-506.

MicroRNA expression signature in gastrointestinal stromal tumour & their molecular & histological features

CircTSN promotes the proliferation and metastasis of gastric cancer through the miR-1825/SLC38A2 signaling axis

Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray

Identification of Gastric Cancer-Related Circular RNA Through Microarray Analysis and Bioinformatics Analysis

Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer

Clinicopathological value of long non-coding RNA profiles in gastrointestinal stromal tumor

Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer

[Expression and Clinical Significance of C-Kit Oncogene in Gastrointestinal Stromal Tumors].

Circular RNA 0001789 Sponges Mir-140-3p and Regulates PAK2 to Promote the Progression of Gastric Cancer.

Abstract 758: Long Non-Coding RNAH19 As a Competing Endogenous RNA of KIT in the Progression of GIST